INTERNATIONAL BIOTECHNOLOGY TRUST PLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 300 filers reported holding SEATTLE GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$12,818,000
+40.5%
65,500
+18.0%
4.14%
+36.4%
Q2 2020$9,123,000
+39.1%
55,500
-2.5%
3.03%
+1.5%
Q1 2020$6,557,000
-10.3%
56,900
-11.1%
2.99%
+13.5%
Q4 2019$7,311,000
+29.0%
64,000
-3.6%
2.63%
+0.6%
Q3 2019$5,667,000
+34.4%
66,400
+9.0%
2.62%
+67.6%
Q2 2019$4,215,000
-5.5%
60,9000.0%1.56%
-5.2%
Q1 2019$4,460,000
+136.0%
60,900
+43.3%
1.65%
+40.5%
Q4 2018$1,890,000
-24.8%
42,5000.0%1.17%
-1.8%
Q3 2018$2,513,000
-10.9%
42,5000.0%1.19%
+10.2%
Q2 2018$2,821,000
+26.9%
42,5000.0%1.08%
+24.9%
Q1 2018$2,223,000
-27.8%
42,500
-26.1%
0.87%
-20.1%
Q4 2017$3,077,000
-1.7%
57,5000.0%1.08%
-10.9%
Q3 2017$3,129,000
-7.0%
57,500
-11.5%
1.22%
-4.7%
Q2 2017$3,363,000
-17.7%
65,0000.0%1.28%
-18.3%
Q1 2017$4,086,00065,0001.56%
Other shareholders
SEATTLE GENETICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Baker Brothers Advisors 45,725,556$2,487,928,00020.18%
Lagoda Investment Management, L.P. 306,694$16,687,0006.03%
NEXTHERA CAPITAL LP 373,000$20,295,0005.22%
Redmile Group, LLC 1,843,733$100,318,0004.95%
Matrix Capital Management Company, LP 2,118,000$115,240,0003.68%
Sio Capital Management, LLC 100,000$5,441,0002.82%
Opus Point Partners Management, LLC 41,263$2,245,0002.01%
Eventide Asset Management 525,000$28,565,0001.62%
EMORY UNIVERSITY 35,982$1,958,0001.55%
Everett Capital Advisors UK LLP 191,500$10,420,0001.54%
View complete list of SEATTLE GENETICS INC shareholders